A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer
NCT00491946 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2007-06-26
Summary
To obtain a preliminary characterization of the plasma PK and metabolites of actinomycin-D in children with cancer.
Conditions
Interventions
- DRUG
-
Actinomycin-D
- DRUG
-
Vincristine
Sponsors & Collaborators
-
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
lead NIH
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-06-30
Countries
- United States
Study Locations
More Related Trials
-
CHildren Treated With Vincristine: A Trial Regarding Pharmacokinetics, DNA And Toxicity of Targeted Therapy In Pediatric Oncology Patients.
NCT05844670 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer
NCT00897871 ·Status: UNKNOWN
-
Drug Sensitivity and Mutation Profiling
NCT04956198 ·Status: COMPLETED
-
Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma
NCT00053326 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy
NCT00001565 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease
NCT00004010 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma
NCT00025610 ·Status: COMPLETED ·Phase: PHASE2
-
Vinblastine and Methotrexate in Treating Children With Desmoid Tumors
NCT00003019 ·Status: COMPLETED ·Phase: PHASE2
-
MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia
NCT01231919 ·Status: COMPLETED ·Phase: PHASE1
-
Vincristine PK and PD in the AYA Population Compared to Younger Children
NCT02360930 ·Status: UNKNOWN
-
Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy
NCT00004919 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma
NCT04994132 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
NCT00381680 ·Status: COMPLETED ·Phase: PHASE3
-
Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid Tumors
NCT03585465 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial
NCT00890435 ·Status: COMPLETED
-
Combination Chemotherapy in Treating Children With Lymphoma
NCT00002590 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of N9 Chemotherapy in Children With Neuroblastoma
NCT04947501 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors
NCT00002489 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics of Drugs Administered to Children
NCT03481881 ·Status: RECRUITING
-
A Pilot Study Investigating the Effects of Acetyl-L-Carnitine and Vincristine-Induced Neuropathy in Pediatric Patients With ALL
NCT02598622 ·Status: TERMINATED ·Phase: PHASE2
-
Vinorelbine in Treating Children With Recurrent or Refractory Cancers
NCT00003234 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study of Perindopril in Childhood Cancer Survivors
NCT01948232 ·Status: WITHDRAWN ·Phase: PHASE2
-
Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors
NCT00024284 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors
NCT00025441 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma
NCT00003958 ·Status: COMPLETED ·Phase: PHASE3